The Evaluation of the Effect of Hypothyroidism Treatment on Non-Alcoholic Fatty Liver Disease
Men's Health Journal,
Vol. 5 No. 1 (2021),
6 January 2021
Introduction: There is still controversy over the existence of a relation between hypothyroidism and fatty liver disease. The scale by which hypothyroidism can affect fatty liver disease progression is also to be determined. Therefore, our study aims to contribute in the determination of this relation. Materials and methods: This observational analytical-before and after study with 53 patients was conducted. The subjects were categorized as having either primary or subclinical hypothyroidism. The serum levels of thyroid stimulation hormone (TSH), free T3 (FT3), free T4 (FT4), alanine transaminase (ALT), aspartate aminotransferase (AST) and alkaline phosphatase (ALP) were measured and liver ultrasound was done to screen nonalcoholic fatty liver disease (NAFLD). Results: The study consisted of 41 women and 12 men with the mean age of 48.3 years. The mean TSH levels decreased after hypothyroidism treatment in patients. The mean levels of FT4 did not have a significant increase after treatment, although in patients with subclinical hypothyroidism this increase was significant. T3 levels increased significantly after treatment. Statistical studies showed that there was a significant change in the degree of fatty liver before and after hypothyroidism treatment. Conclusion: There was an explicit relation between hypothyroidism and non-alcoholic fatty liver disease as Hypothyroidism treatment can prevent non-alcoholic fatty liver disease progression.
- Non-Alcoholic Fatty Liver Disease
How to Cite
Ludwig J, Viggiano TR, Mcgill DB, Oh B, editors. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clinic Proceedings; 1980.
Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis. Annals of internal medicine. 1997;126(2):137-45.
Brunt EM. Pathology of fatty liver disease. Modern Pathology. 2007;20(1):S40-S8.
Lee RG. Nonalcoholic steatohepatitis: a study of 49 patients. Human pathology. 1989;20(6):594-8.
Papandreou D, Rousso I, Mavromichalis I. Update on non-alcoholic fatty liver disease in children. Clinical nutrition. 2007;26(4):409-15.
Patton HM, Sirlin C, Behling C, Middleton M, Schwimmer JB, Lavine JE. Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research. Journal of pediatric gastroenterology and nutrition. 2006;43(4):413-27.
Nonomura A, Mizukam Y, Unoura M, Kobayashi K, Takeda Y, Takeda R. Clinicopathologic study of alcohol-like liver disease in non-alcoholics; non-alcoholic steatohepatitis and fibrosis. Gastroenterologia Japonica. 1992;27(4):521-8.
Arun J, Clements RH, Lazenby AJ, Leeth RR, Abrams GA. The prevalence of nonalcoholic steatohepatitis is greater in morbidly obese men compared to women. Obesity surgery. 2006;16(10):1351-8.
Tunbridge W, Evered D, Hall R, Appleton D, Brewis M, Clark F, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clinical endocrinology. 1977;7(6):481-93.
Vanderpump M, Tunbrldge W, French J, Appleton D, Bates D, Clark F, et al. The incidence of thyroid disorders in the community: a twenty‐year follow‐up of the Whickham Survey. Clinical endocrinology. 1995;43(1):55-68.
Vanderpump MP, Tunbridge WMG. The epidemiology of thyroid diseases. Werner and Ingbar's the thyroid: a fundamental and clinical text. 2005:398-406.
Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Archives of internal medicine. 2000;160(4):526-34.
Kajantie E, Phillips DI, Osmond C, Barker DJ, Forsen T, Eriksson JG. Spontaneous hypothyroidism in adult women is predicted by small body size at birth and during childhood. The Journal of Clinical Endocrinology & Metabolism. 2006;91(12):4953-6.
Surks MI, Hollowell JG. Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. The Journal of Clinical Endocrinology & Metabolism. 2007;92(12):4575-82.
Fauci A, Kasper D, Longo D. Harrison's Principles of Internal Medicine Vol 11. 2008.
Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. The American journal of gastroenterology. 1999;94(9):2467-74.
L’age M, Meinhold H, Wenzel K, Schleusener H. Relations between serum levels of TSH, TBG, T 4, T 3, rT 3 and various histologically classified chronic liver diseases. Journal of endocrinological investigation. 1980;3(4):379-83.
Jamali R, Khonsari M, Merat S, Khoshnia M, Jafari E, Kalhori AB, et al. Persistent alanine aminotransferase elevation among the general Iranian population: prevalence and causes. World journal of Gastroenterology: WJG. 2008;14(18):2867.
Targher G, Byrne CD. Metabolically healthy obesity and NAFLD. Nature reviews gastroenterology & hepatology. 2016;13(8):442-4.
Ueno T, Sugawara H, Sujaku K, Hashimoto O, Tsuji R, Tamaki S, et al. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. Journal of hepatology. 1997;27(1):103-7.
Chung GE, Kim D, Kim W, Yim JY, Park MJ, Kim YJ, et al. Non-alcoholic fatty liver disease across the spectrum of hypothyroidism. Journal of hepatology. 2012;57(1):150-6.
Pagadala MR, Zein CO, Dasarathy S, Yerian LM, Lopez R, McCullough AJ. Prevalence of hypothyroidism in nonalcoholic fatty liver disease. Digestive diseases and sciences. 2012;57(2):528-34.
He W, An X, Li L, Shao X, Li Q, Yao Q, et al. Relationship between hypothyroidism and non-alcoholic fatty liver disease: a systematic review and meta-analysis. Frontiers in endocrinology. 2017;8:335.
Mantovani A, Nascimbeni F, Lonardo A, Zoppini G, Bonora E, Mantzoros CS, et al. Association between primary hypothyroidism and nonalcoholic fatty liver disease: a systematic review and meta-analysis. Thyroid. 2018;28(10):1270-84.
- Abstract Viewed: 0 times
- pdf Downloaded: 0 times